Physical Activity Level in Psychosis Patients
The Effect of Physical Activity Level on Social Participation, Functioning and Quality of Life in Psychosis Patients
1 other identifier
observational
157
1 country
1
Brief Summary
The aim of this study was to examine the effect of physical activity level on social participation, functioning and quality of life in patients with psychosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 20, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 20, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 20, 2024
CompletedFirst Submitted
Initial submission to the registry
May 7, 2024
CompletedFirst Posted
Study publicly available on registry
May 10, 2024
CompletedMay 10, 2024
May 1, 2024
6 months
May 7, 2024
May 7, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
Positive and Negative Syndrome Scale
The scale is a 30-item semi-structured interview scale with a seven-point severity rating. In our study, individuals scoring below 70 points were included to confirm that the participants were not in the active disease period.
6 months
Calgary Schizophrenia Depression Scale
The scale is an interviewer-rated scale and consists of 9 items in four-point Likert type. The cut-off score for schizophrenia accompanied by depressive disorder was determined as 11/12. In our study, individuals scoring below 11 points were included to confirm that the participants were not in a depressive episode.
6 months
Glasgow Antipsychotic Side Effect Rating Scale
It is a 22-item self-report scale about the side effects of antipsychotics. An increase in the scale score indicates an increase in the severity of side effects
6 months
International Physical Activity Form
This form consists of seven questions and provides information on sitting, walking, moderately vigorous activities and time spent in vigorous activities. The calculation of the total score of the short form includes the sum of duration (minutes) and frequency (days) of walking, moderately vigorous activity and vigorous activity. The sitting score (sedentary behavior level) is calculated separately. Physical activity levels are classified as physically inactive/inactive (\<600 MET-min/week), physically inactive/minimally active (600-3000 MET-min/week) and physically active/very active (\>3000 MET-min/week).
6 months
Community Participation Survey
It is a method used to observe an individual's participation in the community. It consists of 15 headings. It is used to assess individuals' home, family life, social activities and work activities. Home activity is 10 points; social activity is 12 points and work activity is 7 points. The total score from 0 to 29 is calculated.
6 months
Brief Functioning Assessment Scale
This scale, which will be used by the researchers, consists of questions designed to measure the extent to which patients experienced difficulties in autonomy, occupational functioning, cognitive functioning, financial issues, interpersonal relations, and leisure time activities during the study. The 24-item scale allows the measurement of 6 different domains of specific functioning: autonomy, occupational, cognitive, financial, interpersonal and leisure activities. The scale provides a total score as well as scores specific to sub-functioning domains. Items are scored according to their severity on a scale of 0 to 4. (0) = no difficulty, (1) = mild difficulty, (2) = moderate difficulty, (3) = severe difficulty. Scores on the scale can range from 0 to 72. A total score above 11 indicates a significant loss of functioning.
6 months
Nottingham Health Profile
It is used to assess the quality of life of individuals. It consists of 2 parts. The first part includes six categories of energy, pain, physical mobility, sleep, emotional reactions and social isolation and consists of 38 different questions with yes or no answers. The second part consists of 7 questions. The questionnaire asks about current complaints. Positive answers to specific areas are used to assess severity or the sum of the six categories can be given as a profile. The total score for each of the 6 sub-parameters is between 0 and 100 and the total score for the total score is between 0 and 600. A high score indicates poor quality of life.
6 months
Eligibility Criteria
Psychosis patients
You may qualify if:
- Patients diagnosed with schizophrenia and other psychotic disorders according to DSM-V criteria (brief psychosis disorder, schizophreniform disorder, schizoaffective disorder, other disorder with psychosis within the scope of another defined schizophrenia and other disorders with psychosis, other disorders with psychosis within the scope of undefined schizophrenia and other disorders with psychosis), who have had their first episode, who are receiving outpatient treatment
- Whose duration of illness is longer than 2 years
- Being between the ages of 18-65
- Being literate
You may not qualify if:
- The participant is in a period of active illness that makes it difficult to conduct research (Positive and Negative Syndrome Scale\>70 scale points, Calgary Depression in Schizophrenia Scale score \>11 scale points)
- Comorbid psychiatric illness
- The patient has an acute or chronic physical illness that impairs the general medical condition and a disease that will affect cognitive functions (neurological, neoplastic, endocrine and immune disorders, infection, epilepsy or any neurological disease, etc.).
- The patient has a physical illness (loss of limbs, paralysis, etc.) that requires additional care and causes significant disability
- Alcohol and substance use disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bandırma Onyedi Eylül University
Balıkesir, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD
Study Record Dates
First Submitted
May 7, 2024
First Posted
May 10, 2024
Study Start
September 20, 2023
Primary Completion
March 20, 2024
Study Completion
April 20, 2024
Last Updated
May 10, 2024
Record last verified: 2024-05